---
title: "Cloudbreak Pharma Sets March 30 Board Meeting to Approve 2025 Annual Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279566205.md"
description: "Cloudbreak Pharma Sets March 30 Board Meeting to Approve 2025 Annual Results"
datetime: "2026-03-18T09:25:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279566205.md)
  - [en](https://longbridge.com/en/news/279566205.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279566205.md)
---

# Cloudbreak Pharma Sets March 30 Board Meeting to Approve 2025 Annual Results

Cloudbreak Pharma Sets March 30 Board Meeting to Approve 2025 Annual Results

### Related Stocks

- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference](https://longbridge.com/en/news/286652404.md)
- [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)